Group 1: Company Announcements - 合富中国's stock price increased by 256.29% over 14 trading days, significantly outperforming the industry and Shanghai Composite Index, leading to a suspension for verification starting November 17 [1] - 工业富联's GB300 achieved mass production in Q3, with improved yield and testing efficiency, positively impacting Q4 gross margin [2] - 天孚通信's controlling shareholder plans to transfer 8.5 million shares, representing 1.09% of total equity, due to personal funding needs [4] - 璞泰来 plans to invest 7.6 billion yuan in a new integrated film coating project, aiming to meet growing demand in the battery and energy storage sectors [5] - 电投能源 intends to acquire 100% of Baiyin Hua Coal Power for 11.149 billion yuan, financing through share issuance and cash [6] - 中微公司 reported that a shareholder completed a reduction of 12.52 million shares, totaling 3.351 billion yuan [7] - 瑞德智能 plans to invest 10 million yuan in a leading company in the power plant robotics sector [8] - 盘古智能 aims to acquire control of a petrochemical company by purchasing 11.97% of its shares for 24.64 million yuan [9] - 泰达股份 signed a memorandum for a waste-to-energy project in Egypt [10] - 杭氧股份 is set to establish a venture capital fund focusing on low-temperature technology and nuclear fusion [11] Group 2: Financial Performance and Regulatory Approvals - 复星医药's subsidiary received FDA approval for a biosimilar drug, with applications pending in China and Europe [21] - 长春高新 received approval for a clinical trial of a new growth hormone drug, with no similar products currently available in China [20] - 海辰药业 obtained a drug registration certificate for a new injection product [22] - 上海机场 reported a 12.46% year-on-year increase in passenger throughput for October [23] Group 3: Shareholder Actions - 深桑达 A plans to publicly transfer 80% of a subsidiary's shares with a minimum price of 1.857 billion yuan [12] - 中电港's major shareholder reduced its stake by 1% between October 31 and November 13 [15] - 康龙化成's major shareholders plan to collectively reduce their holdings by up to 1.5% [16] - 科兴制药's controlling shareholder intends to transfer 5% of its shares [17]

Core Viewpoint - The company Dazhihui (601519.SH) announced that it received a civil ruling from the Shanghai Pudong New District People's Court, allowing the plaintiff Wang Gongwei to withdraw the lawsuit, which will not impact the company's current or future profits [1] Summary by Sections - Legal Proceedings - The company received a civil ruling on November 14, 2025, from the Shanghai Pudong New District People's Court regarding the lawsuit filed by Wang Gongwei [1] - The plaintiff submitted a request to withdraw the lawsuit on the same day, which was granted by the court [1] - Financial Impact - The lawsuit's withdrawal is confirmed to have no effect on the company's current or future profits [1]

证券代码：601519 证券简称：大智慧 编号：临 2025-085 上海大智慧股份有限公司 关于公司涉及诉讼的结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次诉讼的基本情况 原告王功伟于 2025 年 10 月 15 日向上海市浦东新区人民法院提 起诉讼，主张撤销公司 2025 年第二次临时股东大会决议；公司于 2025 年 11 月 10 日收到上海市浦东新区人民法院送达的《应诉通知书》 （【2025】沪 0115 民初 138805 号）等相关诉讼材料。具体内容详见 公司于 2025 年 11 月 12 日在上海证券交易所官网及指定信息披露媒 体上发布的《关于公司涉及诉讼的公告》（公告编号：临 2025-079）。 二、本次诉讼的进展情况 公司于 2025 年 11 月 14 日收到上海市浦东新区人民法院送达的 《民事裁定书》（【2025】沪 0115 民初 138805 号），原告王功伟于 2025 年 11 月 14 日提出撤诉申请，上海市浦东新区人民法院作出裁定：准 许原告王功伟撤 ...

大智慧(601519.SH)公告称，公司于2025年11月14日收到上海市浦东新区人民法院送达的《民事裁定 书》，原告王功伟于2025年11月14日提出撤诉申请，上海市浦东新区人民法院作出裁定：准许原告王功 伟撤诉。 ...

证券代码：601519 证券简称：大智慧 编号：临2025-083 二、公司章程修订情况 鉴于上述情况，公司拟对《公司章程》有关条款进行修改，具体修订情况如下： 1、鉴于公司不再设置监事会，删除"监事"、"监事会"等相关表述，《公司法》规定的监事会职权由"审 计与内控委员会"行使； 上海大智慧股份有限公司 关于取消监事会暨修改《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、公司章程修订背景 根据2024年7月1日实施的《公司法》《关于新〈公司法〉配套制度规则实施相关过渡期安排》《上市公 司章程指引（2025年3月修订）》《上市公司股东会规则（2025年3月修订）》以及《上海证券交易所股 票上市规则（2025年4月修订）》等相关法律、法规和规范性文件的规定，结合公司的实际情况，公司 将不再设置监事会，《公司法》规定的监事会的职权由董事会审计与内控委员会行使，不会影响公司内 部监督机制的正常运行。监事会取消后，《上海大智慧股份有限公司监事会议事规则》等监事会相关制 度将予以废止。 公司分别于2024年6月6 ...

Group 1 - The company held its fifth board meeting on November 13, 2025, where the proposal to cancel the supervisory board and amend the articles of association was approved unanimously by the attending directors [2][43] - The proposal to reappoint Zhongxinghua Accounting Firm as the company's auditor for the fiscal year 2025 was also approved unanimously, with a total audit fee of 1.4 million yuan, which is a reduction of 200,000 yuan from the previous period [15][41] - The proposals from the board will be submitted for approval at the upcoming shareholders' meeting [3][42] Group 2 - The fourth extraordinary shareholders' meeting is scheduled for December 1, 2025, at 1:30 PM, to discuss the approved proposals [21][57] - The meeting will utilize a combination of on-site and online voting methods, with specific time slots for online voting [22][27] - The company encourages shareholders, especially those from remote locations, to participate via online voting to enhance convenience [36][37] Group 3 - Zhongxinghua Accounting Firm, established in 1993, has a total of 1,052 registered accountants and has provided audit services to 169 listed companies in 2024 [6][10] - The firm has a professional risk fund of 10.45 million yuan and a cumulative insurance compensation limit of 10 million yuan, indicating a strong investor protection capability [7] - The project partners and signing accountants have no criminal penalties or administrative sanctions in the past three years, ensuring their integrity and independence [11][12]

Core Viewpoint - The lawsuit filed by individual Wang Gongwei against Dazhihui aims to annul the resolutions passed at the company's second extraordinary general meeting regarding the merger with Xiangcai Co, raising uncertainties about the merger process [5][4]. Group 1: Lawsuit Details - Wang Gongwei filed a lawsuit on October 15, 2025, claiming that Dazhihui did not hire a securities service institution to audit or evaluate the overall assets of Xiangcai Co, and that the resolutions violated company and stock exchange rules [5]. - Dazhihui asserts that it has followed the necessary procedures for the merger and that the resolutions are legally valid, indicating that the lawsuit does not currently involve a specific monetary amount [5][6]. Group 2: Market Reaction - Following the news of the lawsuit, both Dazhihui and Xiangcai Co experienced a significant drop in stock prices, falling over 8% on November 12, with only a slight rebound the next day [3][2]. Group 3: Regulatory Process - The merger has entered the regulatory review stage, with the Shanghai Stock Exchange acknowledging the completeness of the application documents and deciding to accept them for review [6]. - The merger requires approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission before it can be officially implemented, with uncertainties remaining regarding the approval timeline [6]. Group 4: Industry Response - Experts suggest that companies should actively disclose the fair value of the merger target to maintain investor confidence and avoid perceptions of flaws or concealment in major transactions [8]. - It is recommended that companies form specialized legal teams to ensure compliance and address potential litigation proactively, while also maintaining open communication with regulatory bodies [9]. Group 5: Investor Guidance - Investors are advised to closely monitor the company's handling of the lawsuit and its implications for the merger, as a negative court ruling could severely impact stock prices [11]. - It is crucial for investors to assess the compliance and regulatory progress of the merger, focusing on the legitimacy of shareholder meeting resolutions and the opinions of financial and legal advisors [12].

上海大智慧股份有限公司 信息披露管理制度 第一章 总则 第一条 为加强上海大智慧股份有限公司（以下简称"公司"） 信息披露管理水平和信息披露质量，提高公司信息披露工作质量和规 范信息披露程序，保证公司真实、准确、完整、及时、公平地披露信 息，保护公司、股东及其他利益相关人的合法权益，根据《中华人民 共和国公司法》《中华人民共和国证券法》、中国证券监督管理委员 会《上市公司信息披露管理办法》《上海证券交易所股票上市规则》 （以下简称"《股票上市规则》"）、《上海证券交易所上市公司自 律监管指引第 2 号——信息披露事务管理》等有关法律、法规、规章、 规范性文件和《上海大智慧股份有限公司章程》（以下简称"《公司 章程》"）的规定，结合公司实际情况，制定本制度。 第二条 公司设董事会办公室为信息披露事务管理部门。 第三条 本制度所称信息披露是指法律、法规、证券监管部门要 求披露的已经或可能对公司股票交易价格及投资者作出价值判断和 投资决策产生重大影响的信息，在规定的时间内、在规定的媒体上、 按规定的程序及规定的方式向社会公众公布，并按规定程序送达上海 证券交易所和证券监管部门。 第四条 本制度所称直通披露，是指公司 ...

上海大智慧股份有限公司 投资者关系管理制度 第一条 为加强上海大智慧股份有限公司（以下简称"公司"） 与投资者之间的信息沟通，完善公司治理结构，切实保护投资者特别 是社会公众投资者的合法权益，促进证券市场健康稳定发展，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司投资者 关系管理工作指引》《上海证券交易所股票上市规则》（以下简称"《股 票上市规则》"）等有关法律、法规、规章、规范性文件和《上海大 智慧股份有限公司章程》（以下简称"《公司章程》"）的规定，结 合公司实际情况，制定本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息 披露、互动交流和诉求处理等工作，加强与投资者及潜在投资者之间 的沟通，增进投资者对公司的了解和认同，以提升公司治理水平和企 业整体价值，实现尊重投资者、回报投资者、保护投资者目的的相关 活动。 第三条 投资者关系管理的基本原则： 1/11 （二）平等性原则。公司开展投资者关系管理活动，应当平等对 待所有股东及潜在投资者，尤其为中小投资者参与活动创造机会、提 供便利； （三）诚实守信原则。公司在投资者关系管理活动中应当注重诚 信、坚守底线、规范运作、担当 ...

上海大智慧股份有限公司 董事会薪酬与考核委员会工作制度 第六条 薪酬与考核委员会设召集人一名，由独立董事委员担任， 负责主持委员会工作。 第七条 薪酬与考核委员会委员任期与董事任期一致，委员任期 届满，连选可以连任。期间如有委员不再担任公司董事职务或应当具 有独立董事身份的委员不再具备《公司章程》所规定的独立性，自动 失去委员资格，并由董事会根据上述第四至第六条规定补足委员人数。 第八条 薪酬与考核委员会下设工作组，专门负责提供公司有关 经营方面的资料及被考评人员的有关资料，负责筹备薪酬与考核委员 会会议并执行薪酬与考核委员会的有关决议。工作组成员无需是薪酬 与考核委员会委员。 第一章 总则 第一条 为进一步建立健全上海大智慧股份有限公司（以下简称 "公司"）董事及高级管理人员的考核和薪酬管理制度，完善公司治 理结构，根据《中华人民共和国公司法》《上市公司独立董事管理办 法》及《上海大智慧股份有限公司章程》（以下简称"《公司章程》"） 及其他有关法律、行政法规、部门规章和其他规范性文件规定，公司 特设立董事会薪酬与考核委员会，并制定本工作制度。 第二条 薪酬与考核委员会是董事会按照《公司章程》设立的专 门工作 ...